This ADC product is comprised of an anti-CD74 monoclonal antibody (006 (A)) conjugated via a VC linker to MMAE. The MMAE is targeted to Daudi-luc tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten